What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review
Journal of Clinical Medicine · 18.02.2025 · 14 (4) · 1366
DOI: 10.3390/jcm14041366 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.02.2025. Verfasst von Mario Ferraioli und 7 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology, Immunology and Clinical Allergology Unit, Department of Medicina dei Sistemi, University of Rome Tor Vergata, 00133 Rome, Italy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Synovitis–acne–pustulosis–hyperostosis–osteitis (SAPHO) syndrome is a rare disease characterized by a sterile inflammatory osteitis and/or arthritis associated with a wide range of dermatological manifestations, such as acne, palmoplantar pustulosis, and psoriasis. This review, providing up-to-date knowledge on this disease, aims at informing researchers and clinicians to help them program future studies in order to improve patients’ care. Due to the vast clinical heterogeneity that characterizes this disease, SAPHO syndrome has received various names; among these, chronic recurrent multifocal osteomyelitis represents the most used one. The various nomenclatures in use also reflect different approaches to its management. Indeed, considering the world-wide distribution and the vast onset age (from children to late adulthood), in addition to the multiform clinical presentation, its diagnosis and treatment are often challenging for clinicians. In this review, we provide valuable insights on SAPHO syndrome, delving into its many aspects: epidemiology, pathogenesis, clinical presentation, diagnosis, and classification. Most importantly, this paper addresses the continuously changing treatment panorama of this disease, from established drugs to newly introduced ones. Furthermore, a peculiar focus regards nonpharmacologic approaches, including traditional Chinese medicine, the apheresis technique, and surgery. Similarly, this review also discusses patients’ lifestyle, including quality of life. To improve SAPHO syndrome’s management, different knowledge gaps should be filled, such as its current epidemiology and pathogenesis. In turn, perfected knowledge in these fields could also advance research in therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Rheumatology, Immunology and Clinical Allergology Unit, Department of Medicina dei Sistemi, University of Rome Tor Vergata, 00133 Rome, Italy.
- Division of Rheumatology, Department of Experimental and Clinical Medicine, University of Florence, AOU Careggi, 50121 Florence, Italy.
- Rheumatology and Autoinflammatory Diseases, IRCCS Istituto Giannina Gaslini; DINOGMI, University of Genoa, 16126 Genoa, Italy.
ORCID-Profile: Mario Ferraioli, Riccardo De Luca, Caterina Matucci-Cerinic, Marco Gattorno, Silvia Bellando Randone, Maria Sole Chimenti
Zitieren
APA
Ferraioli, M., Levani, J., De Luca, R., Matucci-Cerinic, C., Gattorno, M., Guiducci, S., Bellando Randone, S., & Chimenti, M. S. (2025). What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review. Journal of Clinical Medicine, 14(4), 1366. https://doi.org/10.3390/jcm14041366
Vancouver
Ferraioli M, Levani J, De Luca R, Matucci-Cerinic C, Gattorno M, Guiducci S, et al. What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review. Journal of Clinical Medicine. 2025;14(4):1366. doi:10.3390/jcm14041366
BibTeX
@article{Ferraioli2025,
author = {Ferraioli, Mario and Levani, Juela and De Luca, Riccardo and Matucci-Cerinic, Caterina and Gattorno, Marco and Guiducci, Serena and Bellando Randone, Silvia and Chimenti, Maria Sole},
title = {What Is New and What Is Next for SAPHO Syndrome Management: A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {4},
pages = {1366},
doi = {10.3390/jcm14041366}
}
EUVIMED